Preoperative intravitreal bevacizumab for proliferative diabetic retinopathy patients undergoing vitrectomy - First update

dc.contributor.authorPérez Argandoña, Efraín
dc.contributor.authorVerdaguer, Juan
dc.contributor.authorZacharias, Sergio
dc.contributor.authorGonzález Contreras, Raúl Enrique
dc.date.accessioned2020-11-25T17:34:30Z
dc.date.available2020-11-25T17:34:30Z
dc.date.issued2019
dc.fuente.origenConveris
dc.identifier.doi10.5867/medwave.2019.01.7511
dc.identifier.issn0717-6384
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/49024
dc.identifier.wosidWOS:000483150900002
dc.issue.numeroNo. 1
dc.language.isoen
dc.nota.accesocontenido completo
dc.pagina.final10
dc.pagina.inicio1
dc.revistaMedwavees_ES
dc.rightsacceso abierto
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.titlePreoperative intravitreal bevacizumab for proliferative diabetic retinopathy patients undergoing vitrectomy - First update
dc.typeartículo
dc.volumenVol. 19
sipa.codpersvinculados152763
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Effect of preoperative use of intravitreal bevacizumab in patients with proliferative diabetic retinopathy undergoing vitrectomy - First update.pdf
Size:
2.33 MB
Format:
Adobe Portable Document Format
Description: